✓ Betalning med kreditkort återställd — säker kassahantering via Privacy Shield

Triomune

Triomune (Stavudine + Lamivudine 150 mg + Nevirapine 200 mg) — Cipla older 3-in-1 ART. Replaced by TDF-based regimens in modern WHO guidelines due to mitochondrial toxicity.

Artikelnummer: Triomune Kategori: , ,

Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet  · Senast granskad: maj 2026

Krypterad kassa
Kryptobetalning ger 10% rabatt
Diskret världsomspännande leverans
1 400+ kunder · 50+ länder

Denna produkt är för närvarande slut i lager och inte tillgänglig.

Quick Answer

Triomune — Stavudine 30/40 mg + Lamivudine 150 mg + Nevirapine 200 mg (Cipla Inc). Older 3-in-1 FDC. Stavudine component is mitochondrially toxic; this regimen has been replaced by Trioday (TDF-based) in current WHO guidelines.

Vad du får med MedsBase:

  • WHO-GMP-certifierad tillverkare
  • Discreet plain-envelope packaging
  • Världsvid leverans
  • Rated by 1,400+ customers (read reviews)

📦 Reshipment Assurance: if your order has not arrived 20 business days after dispatch, we reship it at no extra cost. Read the policy.

Varför beställa från MedsBase

Triomune ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

HBV co-infection caveat
If your regimen contains lamivudine, tenofovir, or emtricitabine, these also treat HBV. Test HBsAg and HBV DNA before starting. Stopping abruptly can cause severe HBV flare in co-infected patients — always under hepatology supervision.
Adherence rule
>95% adherence is mandatory. Take at the same time daily, with or without food per the regimen instructions. Missed doses risk resistance, viral rebound, and treatment failure across multiple drug classes simultaneously.

Why fixed-combination regimens

Single-tablet regimens reduce pill burden, improve adherence (proven in multiple trials), simplify dosing, and reduce stigma. They are the preferred form of ART worldwide where available. The trade-off is reduced flexibility — if one component is contraindicated (renal disease, HBV monoinfection, drug interaction), the regimen must be replaced rather than partially adjusted.

Vanliga frågor

What does each component do?

Each fixed-combination has a specific role: NRTI backbone (typically two NRTIs) provides the core of viral suppression; the third agent (NNRTI, INSTI, or PI) closes the regimen. Look at the strengths panel for the exact components.

What if I’m intolerant to one component?

Switch to separate components or a different fixed-combination. Never cut tablets to reduce the dose of an offending component — that risks resistance.

Drug interactions?

Depend on components. Most NRTIs have few interactions; NNRTIs and PIs have many CYP-mediated interactions. Always disclose all medications. Use the Liverpool HIV-DDI database (hiv-druginteractions.org).

Pregnancy?

Safety depends on components. TDF + 3TC + EFV (Trioday) is widely used in pregnancy with extensive safety data. Switch from regimens containing problematic components (high-dose ritonavir, cobicistat, some PIs) under specialist guidance.

Vad händer om jag missar en dos?

Take it when you remember if <6 hours late. If >6 hours late, skip and resume — do not double up. Repeated missed doses risk multi-class resistance.

HBV testing?

Critical — test HBsAg and HBV DNA before starting any regimen containing lamivudine, tenofovir, or emtricitabine. These also treat HBV; stopping risks hepatic flare.

Resistance testing?

Genotypic resistance testing is recommended at HIV diagnosis, before any new regimen, and at virological failure.

U=U?

Yes — Undetectable = Untransmittable. Consistent <200 copies/mL viral load on ART eliminates sexual HIV transmission risk.

Lifelong therapy?

Yes — current ART is lifelong. With consistent adherence, life expectancy approaches that of HIV-negative peers.

When should I see my HIV team?

Routine: every 3-6 months once stable, annual STI screening, vaccinations, cardiometabolic screening. Earlier if symptoms or treatment-failure signals.

Other HIV & Antiviral Medications

  • Trioday — TDF + 3TC + EFV — single-tablet regimen by Cipla
  • Triomune — d4T + 3TC + NVP — older 3-in-1 (stavudine-based)
  • Zepdon — raltegravir 400 mg — integrase inhibitor
  • Abamune L — abacavir + lamivudine — alternative NRTI backbone
  • Tenvir L — tenofovir + lamivudine — alternative NRTI backbone
Medicinsk ansvarsfriskrivning: HIV treatment is a complex, lifelong therapy. Drug choice depends on genotype, resistance testing, comorbidities, and prior treatment history. Discuss any regimen change with an HIV specialist. Adherence >95% is required to prevent resistance. Test for HBV before starting any tenofovir-, lamivudine-, or emtricitabine-containing regimen — withdrawal can cause severe HBV flare in co-infected patients.

More options in HIV Medication

Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.

Styrka

30+150+200 mg, 40+150+200 mg

Kvantitet

30 Tablet/s, 60 Tablet/s, 90 Tablet/s

Pharma Form

Capsule/s

Manufacturer

Cipla Inc

Treatment

HIV Infection

Generic Brand

Stavudine + Lamivudine + Nevirapine

Recensioner

Det finns inga recensioner än

Skriv en recension
Triomune Triomune
Betyg*
0/5
* Betyg är obligatoriskt
* Svar är obligatoriskt
Din recension
* Recension är obligatorisk
Namn
* Namn är obligatoriskt
Lägg till foton eller video i din recension

Frågor & svar

Ställ en fråga
Triomune Triomune
Din fråga
* Fråga är obligatorisk
Namn
* Namn är obligatoriskt
Det finns inga frågor än